Cannara Biotech Upgrades to OTCQX, Begins Trading as LOVFF

OTCQX status signals stronger financials, rigorous governance, enhanced disclosure, expanding U.S. investor visibility.

Overview

Cannara Biotech began trading on the OTCQX Best Market on January 14 under the ticker LOVFF after upgrading from the OTCQB Venture Market, and it remains listed on the TSX‑V.
OTC Markets Group describes OTCQX as a venue for established companies that meet high financial standards, follow best‑practice corporate governance, and comply with applicable securities laws.
U.S. investors can now access the company’s current financial disclosures and Real‑Time Level 2 quotes on otcmarkets.com.
Chief financial officer Nicholas Sosiak said the move reflects continued operational execution, strengthening financial performance, sustained revenue growth, improving margins, and increased scale while enhancing visibility with U.S. investors.
The company describes itself as a vertically integrated Canadian cannabis producer with two Québec facilities totaling over 1.65 million square feet and up to 100,000 kilograms of potential annual cultivation output, supported by low local electricity costs.